About Sirnaomics
Sirnaomics is a company based in Gaithersburg (United States) founded in 2007.. Sirnaomics has raised $267 million across 17 funding rounds from investors including Maryland.gov, HHS and Bloomage Biotechnology. The company has 69 employees as of December 31, 2024. Sirnaomics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others.
- Headquarter Gaithersburg, United States
- Employees 69 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sirnaomics Ltd.
-
Annual Revenue
$1.79 M (USD)0as on Dec 31, 2024
-
Net Profit
$-51.62 M (USD)34.92as on Dec 31, 2024
-
EBITDA
$-31.35 M (USD)56.43as on Dec 31, 2024
-
Total Equity Funding
$267 M (USD)
in 17 rounds
-
Latest Funding Round
$17.69 M (USD), Post-IPO
Sep 07, 2025
-
Investors
Maryland.gov
& 14 more
-
Employee Count
69
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sirnaomics
Sirnaomics is a publicly listed company on the HKEX with ticker symbol 2257 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Sirnaomics
Sirnaomics has successfully raised a total of $267M across 17 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.69 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 17
- Last Round Post-IPO — $17.7M
- First Round First Round
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Post-IPO - Sirnaomics | Valuation |
investors |
|
| Jul, 2021 | Amount | Series E - Sirnaomics | Valuation | Rotating Boulder Fund |
|
| Oct, 2020 | Amount | Series D - Sirnaomics | Valuation | Rotating Boulder Fund , Walvax |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sirnaomics
Sirnaomics has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Maryland.gov, HHS and Bloomage Biotechnology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in blockchain industry
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sirnaomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sirnaomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sirnaomics Comparisons
Competitors of Sirnaomics
Sirnaomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sirnaomics
Frequently Asked Questions about Sirnaomics
When was Sirnaomics founded?
Sirnaomics was founded in 2007.
Where is Sirnaomics located?
Sirnaomics is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Is Sirnaomics a funded company?
Sirnaomics is a funded company, having raised a total of $267M across 17 funding rounds to date. The company's 1st funding round was a Series D of $105M, raised on Dec 26, 2007.
How many employees does Sirnaomics have?
As of Dec 31, 2024, the latest employee count at Sirnaomics is 69.
What is the annual revenue of Sirnaomics?
Annual revenue of Sirnaomics is $1.79M as on Dec 31, 2024.
What does Sirnaomics do?
Sirnaomics was founded in 2007 and is located in Gaithersburg, United States. RNA-based therapeutics are developed for cancer and fibrosis treatment within the biotechnology sector. Proprietary delivery technologies, including a polypeptide nanoparticle RNAi platform and the GalNAc RNAi platform known as GalAhead, are employed to advance a drug candidate pipeline. This pipeline targets cardiovascular disease, cancers, skin conditions, fibrosis-related diseases, antiviral applications, cardiometabolic conditions, and medical aesthetics.
Who are the top competitors of Sirnaomics?
Sirnaomics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Is Sirnaomics publicly traded?
Yes, Sirnaomics is publicly traded on HKEX under the ticker symbol 2257.
Who are Sirnaomics's investors?
Sirnaomics has 15 investors. Key investors include Maryland.gov, HHS, Bloomage Biotechnology, Yuexiu Group, and Walvax.
What is Sirnaomics's ticker symbol?
The ticker symbol of Sirnaomics is 2257 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.